Bioprocess Containers Market by Type (2D Bags, 3D Bags, Tank Liners), Application (Process Development, Upstream, and Downstream), End Users (Biopharmaceutical, and Life Science Companies), and Region - Global Forecast to 2023
|出版日||ページ情報||英文 105 Pages
|バイオプロセスコンテナの世界市場の予測 (～2023年)：2Dバッグ・3Dバッグ・タンクライナー Bioprocess Containers Market by Type (2D Bags, 3D Bags, Tank Liners), Application (Process Development, Upstream, and Downstream), End Users (Biopharmaceutical, and Life Science Companies), and Region - Global Forecast to 2023|
|出版日: 2018年04月12日||ページ情報: 英文 105 Pages||
世界のバイオプロセスコンテナの市場は予測期間中13.2%のCAGR (年間複合成長率) で推移し、2018年の10億3000万米ドルから、2023年には19億1460万米ドルの規模に成長すると予測されています。生物学的製剤の需要の拡大、単回使用バイオプロセス技術の価格受容性と持続可能性、単回使用ディスポ技術を用いたワクチン製造、相互汚染の低リスク性などの要因が同市場の成長を推進しています。
The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 1,030.0 million in 2018, at a CAGR of 13.2%. Growth in this market can be attributed to the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination. Most of these conventional biomanufacturing products require constant sterilization to eliminate contamination, which increases the overall investments for manufacturers. Hence, transition from conventional equipment to single-use systems results in the frequent growth of this market.
Based on type, bioprocess containers market is segmented in to 2D bioprocess containers, 3D bioprocess containers, and other containers and accessories. The 3D bioprocess containers segment is estimated to register the highest CAGR during the forecast period. The significant reductions in labor cost and the faster batch-turnaround achieved using these containers are the major factor driving their adoption.
Based on end user, the bioprocess containers market is segmented into biopharmaceutical companies and life science R&D companies. The life science R&D companies segment is expected to grow at the fastest growth rate during the forecast period. The R&D and manufacturing of biologics and biosimilars are extremely expensive due to the amount of detail necessary to replicate and ensure the validation of biosynthesis of living cells and their components. This factor primarily contributes to the growth of this end user segment.
Geographically, the bioprocess containers market is dominated by North America, followed by Europe in 2018. The Asian region is estimated to grow at the fastest rate which can be attributed to the significant investments by key market players, increasing government support, developing R&D infrastructure, increasing outsourcing of pharmaceutical manufacturing and R&D, and increasing cell culture distribution. For instance, in May 2017, Merck KGaA established its first joint bioprocess scale-up laboratory with Stelis Biopharma in India.
The primary interviews conducted for this report can be categorized as follows:
The key players in the bioprocess containers market are: Thermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).
The report analyzes the bioprocess containers market by type, application, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful.
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.